nodes	percent_of_prediction	percent_of_DWPC	metapath
Meloxicam—PTGS1—ulcerative colitis	0.164	0.636	CbGaD
Meloxicam—osteoarthritis—Prednisone—ulcerative colitis	0.146	0.5	CpDpCtD
Meloxicam—osteoarthritis—Methylprednisolone—ulcerative colitis	0.146	0.5	CpDpCtD
Meloxicam—PTGS2—ulcerative colitis	0.094	0.364	CbGaD
Meloxicam—PTGS2—Olsalazine—ulcerative colitis	0.0379	0.107	CbGbCtD
Meloxicam—PTGS2—Balsalazide—ulcerative colitis	0.0338	0.0955	CbGbCtD
Meloxicam—PTGS1—Olsalazine—ulcerative colitis	0.032	0.0904	CbGbCtD
Meloxicam—ABCC4—Mercaptopurine—ulcerative colitis	0.0315	0.089	CbGbCtD
Meloxicam—PTGS1—Balsalazide—ulcerative colitis	0.0285	0.0806	CbGbCtD
Meloxicam—PTGS2—Mesalazine—ulcerative colitis	0.027	0.0763	CbGbCtD
Meloxicam—PTGS1—Mesalazine—ulcerative colitis	0.0228	0.0644	CbGbCtD
Meloxicam—PTGS2—Sulfasalazine—ulcerative colitis	0.0151	0.0426	CbGbCtD
Meloxicam—PTGS2—Triamcinolone—ulcerative colitis	0.0151	0.0426	CbGbCtD
Meloxicam—PTGS2—Betamethasone—ulcerative colitis	0.0129	0.0366	CbGbCtD
Meloxicam—PTGS1—Sulfasalazine—ulcerative colitis	0.0127	0.036	CbGbCtD
Meloxicam—CYP2C8—Nicotine—ulcerative colitis	0.00945	0.0267	CbGbCtD
Meloxicam—CYP3A4—Budesonide—ulcerative colitis	0.00881	0.0249	CbGbCtD
Meloxicam—CYP2C8—Cholecalciferol—ulcerative colitis	0.00848	0.024	CbGbCtD
Meloxicam—PTGS2—Dexamethasone—ulcerative colitis	0.00753	0.0213	CbGbCtD
Meloxicam—CYP2C9—Nicotine—ulcerative colitis	0.00659	0.0186	CbGbCtD
Meloxicam—CYP2C9—Cholecalciferol—ulcerative colitis	0.00591	0.0167	CbGbCtD
Meloxicam—CYP2C8—Hydrocortisone—ulcerative colitis	0.0059	0.0167	CbGbCtD
Meloxicam—CYP3A4—Methylprednisolone—ulcerative colitis	0.00393	0.0111	CbGbCtD
Meloxicam—CYP3A4—Nicotine—ulcerative colitis	0.00383	0.0108	CbGbCtD
Meloxicam—CYP2C8—Dexamethasone—ulcerative colitis	0.00367	0.0104	CbGbCtD
Meloxicam—CYP3A4—Cholecalciferol—ulcerative colitis	0.00344	0.00972	CbGbCtD
Meloxicam—CYP3A4—Triamcinolone—ulcerative colitis	0.00298	0.00843	CbGbCtD
Meloxicam—CYP2C9—Dexamethasone—ulcerative colitis	0.00256	0.00723	CbGbCtD
Meloxicam—CYP3A4—Betamethasone—ulcerative colitis	0.00256	0.00723	CbGbCtD
Meloxicam—CYP3A4—Prednisolone—ulcerative colitis	0.00252	0.00713	CbGbCtD
Meloxicam—CYP3A4—Hydrocortisone—ulcerative colitis	0.00239	0.00676	CbGbCtD
Meloxicam—CYP3A4—Prednisone—ulcerative colitis	0.00238	0.00674	CbGbCtD
Meloxicam—CYP3A4—Dexamethasone—ulcerative colitis	0.00149	0.00421	CbGbCtD
Meloxicam—PGD—NRF2 pathway—SLC39A11—ulcerative colitis	0.000689	0.0658	CbGpPWpGaD
Meloxicam—Lornoxicam—PTGS1—ulcerative colitis	0.000646	0.243	CrCbGaD
Meloxicam—PTGS1—Overview of nanoparticle effects—CDH3—ulcerative colitis	0.000636	0.0608	CbGpPWpGaD
Meloxicam—Tenoxicam—PTGS1—ulcerative colitis	0.000576	0.216	CrCbGaD
Meloxicam—PTGS2—Overview of nanoparticle effects—CDH3—ulcerative colitis	0.000505	0.0483	CbGpPWpGaD
Meloxicam—PTGS2—Fluocinonide—Budesonide—ulcerative colitis	0.000417	0.247	CbGdCrCtD
Meloxicam—Lornoxicam—PTGS2—ulcerative colitis	0.000369	0.139	CrCbGaD
Meloxicam—Piroxicam—PTGS1—ulcerative colitis	0.000356	0.134	CrCbGaD
Meloxicam—Tenoxicam—PTGS2—ulcerative colitis	0.000329	0.124	CrCbGaD
Meloxicam—PTGS2—Calcium signaling in the CD4+ TCR pathway—CHP1—ulcerative colitis	0.000306	0.0293	CbGpPWpGaD
Meloxicam—ABCC4—NRF2 pathway—SLC39A11—ulcerative colitis	0.000274	0.0262	CbGpPWpGaD
Meloxicam—ABCC4—Drug Induction of Bile Acid Pathway—ABCB1—ulcerative colitis	0.000245	0.0234	CbGpPWpGaD
Meloxicam—ABCC4—Drug Induction of Bile Acid Pathway—VDR—ulcerative colitis	0.000245	0.0234	CbGpPWpGaD
Meloxicam—PGD—Carbohydrate metabolism—CHP1—ulcerative colitis	0.000239	0.0228	CbGpPWpGaD
Meloxicam—PTGS2—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS1—ulcerative colitis	0.000229	0.0219	CbGpPWpGaD
Meloxicam—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IKZF1—ulcerative colitis	0.000208	0.0198	CbGpPWpGaD
Meloxicam—Piroxicam—PTGS2—ulcerative colitis	0.000203	0.0764	CrCbGaD
Meloxicam—PTGS2—Fluocinonide—Methylprednisolone—ulcerative colitis	0.000201	0.119	CbGdCrCtD
Meloxicam—PTGS2—Fluocinonide—Dexamethasone—ulcerative colitis	0.000198	0.118	CbGdCrCtD
Meloxicam—PTGS2—Fluocinonide—Betamethasone—ulcerative colitis	0.000198	0.118	CbGdCrCtD
Meloxicam—PTGS2—Fluocinonide—Triamcinolone—ulcerative colitis	0.000194	0.115	CbGdCrCtD
Meloxicam—Piroxicam—ALB—ulcerative colitis	0.000181	0.0681	CrCbGaD
Meloxicam—PTGS2—C-MYB transcription factor network—PRTN3—ulcerative colitis	0.000181	0.0173	CbGpPWpGaD
Meloxicam—PTGS2—Overview of nanoparticle effects—PTGS1—ulcerative colitis	0.000179	0.0171	CbGpPWpGaD
Meloxicam—PTGS1—Prostaglandin Synthesis and Regulation—PTGER4—ulcerative colitis	0.000159	0.0152	CbGpPWpGaD
Meloxicam—PTGS2—Eicosanoid Synthesis—PTGS1—ulcerative colitis	0.000149	0.0142	CbGpPWpGaD
Meloxicam—ABCC4—ABC-family proteins mediated transport—ABCB1—ulcerative colitis	0.000135	0.0129	CbGpPWpGaD
Meloxicam—PTGS1—Overview of nanoparticle effects—CRP—ulcerative colitis	0.000129	0.0123	CbGpPWpGaD
Meloxicam—PTGS2—Prostaglandin Synthesis and Regulation—PTGER4—ulcerative colitis	0.000126	0.0121	CbGpPWpGaD
Meloxicam—PTGS2—Prostaglandin Synthesis and Regulation—PTGS1—ulcerative colitis	0.000124	0.0119	CbGpPWpGaD
Meloxicam—PTGS2—Fluticasone Propionate—Methylprednisolone—ulcerative colitis	0.000121	0.0721	CbGdCrCtD
Meloxicam—PTGS2—Fluticasone Propionate—Betamethasone—ulcerative colitis	0.00012	0.071	CbGdCrCtD
Meloxicam—PTGS2—Fluticasone Propionate—Dexamethasone—ulcerative colitis	0.00012	0.071	CbGdCrCtD
Meloxicam—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—MMP1—ulcerative colitis	0.000119	0.0114	CbGpPWpGaD
Meloxicam—PTGS2—Fluticasone Propionate—Triamcinolone—ulcerative colitis	0.000117	0.0693	CbGdCrCtD
Meloxicam—PTGS2—Calcium signaling in the CD4+ TCR pathway—CALM3—ulcerative colitis	0.000115	0.011	CbGpPWpGaD
Meloxicam—PTGS1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS2—ulcerative colitis	0.00011	0.0106	CbGpPWpGaD
Meloxicam—CYP3A4—Codeine and Morphine Metabolism—ABCB1—ulcerative colitis	0.000109	0.0105	CbGpPWpGaD
Meloxicam—PTGS2—Overview of nanoparticle effects—CRP—ulcerative colitis	0.000102	0.00979	CbGpPWpGaD
Meloxicam—ABCC4—Platelet degranulation—CALM3—ulcerative colitis	9.13e-05	0.00873	CbGpPWpGaD
Meloxicam—PGD—Carbohydrate metabolism—CALM3—ulcerative colitis	8.96e-05	0.00857	CbGpPWpGaD
Meloxicam—ABCC4—Response to elevated platelet cytosolic Ca2+—CALM3—ulcerative colitis	8.7e-05	0.00832	CbGpPWpGaD
Meloxicam—PTGS1—Overview of nanoparticle effects—PTGS2—ulcerative colitis	8.65e-05	0.00827	CbGpPWpGaD
Meloxicam—PTGS1—Overview of nanoparticle effects—CXCL8—ulcerative colitis	8.39e-05	0.00802	CbGpPWpGaD
Meloxicam—PTGS2—Arachidonic acid metabolism—PTGS1—ulcerative colitis	8.26e-05	0.0079	CbGpPWpGaD
Meloxicam—ABCC4—Hemostasis—PROCR—ulcerative colitis	7.69e-05	0.00735	CbGpPWpGaD
Meloxicam—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CALM3—ulcerative colitis	7.44e-05	0.00711	CbGpPWpGaD
Meloxicam—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CTLA4—ulcerative colitis	7.22e-05	0.0069	CbGpPWpGaD
Meloxicam—PTGS1—Selenium Micronutrient Network—MPO—ulcerative colitis	7.2e-05	0.00688	CbGpPWpGaD
Meloxicam—PTGS1—Eicosanoid Synthesis—PTGS2—ulcerative colitis	7.18e-05	0.00686	CbGpPWpGaD
Meloxicam—PTGS2—Spinal Cord Injury—MIF—ulcerative colitis	6.97e-05	0.00666	CbGpPWpGaD
Meloxicam—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—NFKB1—ulcerative colitis	6.84e-05	0.00654	CbGpPWpGaD
Meloxicam—PGD—Disease—CHP1—ulcerative colitis	6.76e-05	0.00646	CbGpPWpGaD
Meloxicam—CYP2C8—Arachidonic acid metabolism—PTGS1—ulcerative colitis	6.72e-05	0.00643	CbGpPWpGaD
Meloxicam—PTGS2—Overview of nanoparticle effects—CXCL8—ulcerative colitis	6.66e-05	0.00637	CbGpPWpGaD
Meloxicam—ABCC4—Transmembrane transport of small molecules—SLC26A3—ulcerative colitis	6.65e-05	0.00636	CbGpPWpGaD
Meloxicam—PTGS2—Integrated Pancreatic Cancer Pathway—MST1—ulcerative colitis	6.04e-05	0.00577	CbGpPWpGaD
Meloxicam—PTGS1—Prostaglandin Synthesis and Regulation—PTGS2—ulcerative colitis	6e-05	0.00574	CbGpPWpGaD
Meloxicam—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—ulcerative colitis	5.99e-05	0.00572	CbGpPWpGaD
Meloxicam—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—ulcerative colitis	5.98e-05	0.00571	CbGpPWpGaD
Meloxicam—PTGS2—C-MYB transcription factor network—MPO—ulcerative colitis	5.93e-05	0.00567	CbGpPWpGaD
Meloxicam—PTGS1—Overview of nanoparticle effects—TNF—ulcerative colitis	5.84e-05	0.00558	CbGpPWpGaD
Meloxicam—ABCC4—Platelet activation, signaling and aggregation—GNA12—ulcerative colitis	5.82e-05	0.00556	CbGpPWpGaD
Meloxicam—PTGS2—Selenium Micronutrient Network—MPO—ulcerative colitis	5.71e-05	0.00546	CbGpPWpGaD
Meloxicam—PGD—Metabolism—CHP1—ulcerative colitis	5.66e-05	0.00541	CbGpPWpGaD
Meloxicam—CYP2C9—Constitutive Androstane Receptor Pathway—ABCB1—ulcerative colitis	5.48e-05	0.00523	CbGpPWpGaD
Meloxicam—CYP2C9—Arachidonic acid metabolism—PTGS1—ulcerative colitis	5.47e-05	0.00523	CbGpPWpGaD
Meloxicam—PGD—Disease—SEL1L—ulcerative colitis	5.37e-05	0.00513	CbGpPWpGaD
Meloxicam—PTGS2—Selenium Micronutrient Network—PTGS1—ulcerative colitis	5.26e-05	0.00502	CbGpPWpGaD
Meloxicam—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—ulcerative colitis	5.22e-05	0.00499	CbGpPWpGaD
Meloxicam—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—ulcerative colitis	5.21e-05	0.00498	CbGpPWpGaD
Meloxicam—PTGS2—Calcium signaling in the CD4+ TCR pathway—IFNG—ulcerative colitis	5.11e-05	0.00488	CbGpPWpGaD
Meloxicam—PGD—Metabolism—DLD—ulcerative colitis	4.89e-05	0.00467	CbGpPWpGaD
Meloxicam—PGD—Disease—LTF—ulcerative colitis	4.82e-05	0.0046	CbGpPWpGaD
Meloxicam—PTGS1—Overview of nanoparticle effects—IL6—ulcerative colitis	4.71e-05	0.0045	CbGpPWpGaD
Meloxicam—CYP2C8—Phase 1 - Functionalization of compounds—PTGS1—ulcerative colitis	4.71e-05	0.0045	CbGpPWpGaD
Meloxicam—ABCC4—Fluoropyrimidine Activity—TP53—ulcerative colitis	4.7e-05	0.00449	CbGpPWpGaD
Meloxicam—PTGS2—Overview of nanoparticle effects—TNF—ulcerative colitis	4.64e-05	0.00443	CbGpPWpGaD
Meloxicam—PTGS2—Spinal Cord Injury—FCGR2A—ulcerative colitis	4.57e-05	0.00437	CbGpPWpGaD
Meloxicam—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2—ulcerative colitis	4.54e-05	0.00434	CbGpPWpGaD
Meloxicam—ABCC4—Platelet degranulation—ALB—ulcerative colitis	4.44e-05	0.00425	CbGpPWpGaD
Meloxicam—PGD—NRF2 pathway—TGFB1—ulcerative colitis	4.36e-05	0.00417	CbGpPWpGaD
Meloxicam—Myalgia—Triamcinolone—ulcerative colitis	4.32e-05	0.000535	CcSEcCtD
Meloxicam—Vomiting—Azathioprine—ulcerative colitis	4.32e-05	0.000535	CcSEcCtD
Meloxicam—Nervous system disorder—Hydrocortisone—ulcerative colitis	4.31e-05	0.000534	CcSEcCtD
Meloxicam—Myalgia—Methylprednisolone—ulcerative colitis	4.31e-05	0.000534	CcSEcCtD
Meloxicam—Arthralgia—Methylprednisolone—ulcerative colitis	4.31e-05	0.000534	CcSEcCtD
Meloxicam—Eye disorder—Prednisone—ulcerative colitis	4.3e-05	0.000533	CcSEcCtD
Meloxicam—Anxiety—Methylprednisolone—ulcerative colitis	4.29e-05	0.000532	CcSEcCtD
Meloxicam—Tachycardia—Hydrocortisone—ulcerative colitis	4.29e-05	0.000532	CcSEcCtD
Meloxicam—Rash—Azathioprine—ulcerative colitis	4.28e-05	0.00053	CcSEcCtD
Meloxicam—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ulcerative colitis	4.28e-05	0.00053	CcSEcCtD
Meloxicam—Dermatitis—Azathioprine—ulcerative colitis	4.28e-05	0.00053	CcSEcCtD
Meloxicam—Flushing—Prednisone—ulcerative colitis	4.27e-05	0.00053	CcSEcCtD
Meloxicam—Skin disorder—Hydrocortisone—ulcerative colitis	4.27e-05	0.000529	CcSEcCtD
Meloxicam—Ill-defined disorder—Dexamethasone—ulcerative colitis	4.27e-05	0.000529	CcSEcCtD
Meloxicam—Ill-defined disorder—Betamethasone—ulcerative colitis	4.27e-05	0.000529	CcSEcCtD
Meloxicam—Discomfort—Triamcinolone—ulcerative colitis	4.27e-05	0.000529	CcSEcCtD
Meloxicam—Discomfort—Methylprednisolone—ulcerative colitis	4.26e-05	0.000528	CcSEcCtD
Meloxicam—Headache—Azathioprine—ulcerative colitis	4.25e-05	0.000527	CcSEcCtD
Meloxicam—Hyperhidrosis—Hydrocortisone—ulcerative colitis	4.25e-05	0.000527	CcSEcCtD
Meloxicam—ABCC4—Response to elevated platelet cytosolic Ca2+—ALB—ulcerative colitis	4.23e-05	0.00405	CbGpPWpGaD
Meloxicam—Diarrhoea—Mesalazine—ulcerative colitis	4.23e-05	0.000524	CcSEcCtD
Meloxicam—Dry mouth—Triamcinolone—ulcerative colitis	4.22e-05	0.000524	CcSEcCtD
Meloxicam—Angioedema—Betamethasone—ulcerative colitis	4.21e-05	0.000521	CcSEcCtD
Meloxicam—Angioedema—Dexamethasone—ulcerative colitis	4.21e-05	0.000521	CcSEcCtD
Meloxicam—Angiopathy—Prednisone—ulcerative colitis	4.18e-05	0.000518	CcSEcCtD
Meloxicam—Confusional state—Methylprednisolone—ulcerative colitis	4.16e-05	0.000516	CcSEcCtD
Meloxicam—Immune system disorder—Prednisone—ulcerative colitis	4.16e-05	0.000516	CcSEcCtD
Meloxicam—Malaise—Betamethasone—ulcerative colitis	4.15e-05	0.000514	CcSEcCtD
Meloxicam—Malaise—Dexamethasone—ulcerative colitis	4.15e-05	0.000514	CcSEcCtD
Meloxicam—Anaphylactic shock—Triamcinolone—ulcerative colitis	4.14e-05	0.000513	CcSEcCtD
Meloxicam—Oedema—Triamcinolone—ulcerative colitis	4.14e-05	0.000513	CcSEcCtD
Meloxicam—Vertigo—Betamethasone—ulcerative colitis	4.13e-05	0.000513	CcSEcCtD
Meloxicam—Vertigo—Dexamethasone—ulcerative colitis	4.13e-05	0.000513	CcSEcCtD
Meloxicam—Anaphylactic shock—Methylprednisolone—ulcerative colitis	4.13e-05	0.000512	CcSEcCtD
Meloxicam—Syncope—Betamethasone—ulcerative colitis	4.13e-05	0.000512	CcSEcCtD
Meloxicam—Syncope—Dexamethasone—ulcerative colitis	4.13e-05	0.000512	CcSEcCtD
Meloxicam—Arrhythmia—Prednisone—ulcerative colitis	4.11e-05	0.00051	CcSEcCtD
Meloxicam—Infection—Triamcinolone—ulcerative colitis	4.11e-05	0.00051	CcSEcCtD
Meloxicam—Hypotension—Hydrocortisone—ulcerative colitis	4.11e-05	0.000509	CcSEcCtD
Meloxicam—Infection—Methylprednisolone—ulcerative colitis	4.1e-05	0.000509	CcSEcCtD
Meloxicam—Dizziness—Mesalazine—ulcerative colitis	4.09e-05	0.000507	CcSEcCtD
Meloxicam—Shock—Triamcinolone—ulcerative colitis	4.07e-05	0.000505	CcSEcCtD
Meloxicam—Insomnia—Prednisolone—ulcerative colitis	4.07e-05	0.000505	CcSEcCtD
Meloxicam—Alopecia—Prednisone—ulcerative colitis	4.07e-05	0.000504	CcSEcCtD
Meloxicam—Shock—Methylprednisolone—ulcerative colitis	4.06e-05	0.000504	CcSEcCtD
Meloxicam—ABCC4—Platelet activation, signaling and aggregation—CALM3—ulcerative colitis	4.05e-05	0.00387	CbGpPWpGaD
Meloxicam—Nervous system disorder—Methylprednisolone—ulcerative colitis	4.05e-05	0.000502	CcSEcCtD
Meloxicam—Loss of consciousness—Betamethasone—ulcerative colitis	4.05e-05	0.000501	CcSEcCtD
Meloxicam—Loss of consciousness—Dexamethasone—ulcerative colitis	4.05e-05	0.000501	CcSEcCtD
Meloxicam—Paraesthesia—Prednisolone—ulcerative colitis	4.04e-05	0.000501	CcSEcCtD
Meloxicam—Tachycardia—Triamcinolone—ulcerative colitis	4.04e-05	0.000501	CcSEcCtD
Meloxicam—Mental disorder—Prednisone—ulcerative colitis	4.03e-05	0.0005	CcSEcCtD
Meloxicam—Nausea—Azathioprine—ulcerative colitis	4.03e-05	0.0005	CcSEcCtD
Meloxicam—Tachycardia—Methylprednisolone—ulcerative colitis	4.03e-05	0.0005	CcSEcCtD
Meloxicam—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PPARG—ulcerative colitis	4.03e-05	0.00385	CbGpPWpGaD
Meloxicam—Skin disorder—Methylprednisolone—ulcerative colitis	4.01e-05	0.000497	CcSEcCtD
Meloxicam—Malnutrition—Prednisone—ulcerative colitis	4.01e-05	0.000497	CcSEcCtD
Meloxicam—Erythema—Prednisone—ulcerative colitis	4.01e-05	0.000497	CcSEcCtD
Meloxicam—Musculoskeletal discomfort—Hydrocortisone—ulcerative colitis	4.01e-05	0.000497	CcSEcCtD
Meloxicam—Hyperhidrosis—Triamcinolone—ulcerative colitis	4e-05	0.000496	CcSEcCtD
Meloxicam—Hyperhidrosis—Methylprednisolone—ulcerative colitis	3.99e-05	0.000495	CcSEcCtD
Meloxicam—PTGS1—Arachidonic acid metabolism—PTGS2—ulcerative colitis	3.99e-05	0.00381	CbGpPWpGaD
Meloxicam—Convulsion—Betamethasone—ulcerative colitis	3.99e-05	0.000494	CcSEcCtD
Meloxicam—Convulsion—Dexamethasone—ulcerative colitis	3.99e-05	0.000494	CcSEcCtD
Meloxicam—Insomnia—Hydrocortisone—ulcerative colitis	3.98e-05	0.000493	CcSEcCtD
Meloxicam—Hypertension—Dexamethasone—ulcerative colitis	3.97e-05	0.000493	CcSEcCtD
Meloxicam—Hypertension—Betamethasone—ulcerative colitis	3.97e-05	0.000493	CcSEcCtD
Meloxicam—Paraesthesia—Hydrocortisone—ulcerative colitis	3.95e-05	0.000489	CcSEcCtD
Meloxicam—Vomiting—Mesalazine—ulcerative colitis	3.93e-05	0.000487	CcSEcCtD
Meloxicam—ABCC4—Transmembrane transport of small molecules—SLC22A4—ulcerative colitis	3.92e-05	0.00375	CbGpPWpGaD
Meloxicam—ABCC4—Transmembrane transport of small molecules—SLC22A5—ulcerative colitis	3.92e-05	0.00375	CbGpPWpGaD
Meloxicam—Myalgia—Betamethasone—ulcerative colitis	3.92e-05	0.000486	CcSEcCtD
Meloxicam—Myalgia—Dexamethasone—ulcerative colitis	3.92e-05	0.000486	CcSEcCtD
Meloxicam—Anxiety—Dexamethasone—ulcerative colitis	3.9e-05	0.000484	CcSEcCtD
Meloxicam—Anxiety—Betamethasone—ulcerative colitis	3.9e-05	0.000484	CcSEcCtD
Meloxicam—Rash—Mesalazine—ulcerative colitis	3.9e-05	0.000483	CcSEcCtD
Meloxicam—Dermatitis—Mesalazine—ulcerative colitis	3.89e-05	0.000483	CcSEcCtD
Meloxicam—Headache—Mesalazine—ulcerative colitis	3.87e-05	0.00048	CcSEcCtD
Meloxicam—Discomfort—Dexamethasone—ulcerative colitis	3.87e-05	0.00048	CcSEcCtD
Meloxicam—Discomfort—Betamethasone—ulcerative colitis	3.87e-05	0.00048	CcSEcCtD
Meloxicam—Dyspepsia—Hydrocortisone—ulcerative colitis	3.87e-05	0.00048	CcSEcCtD
Meloxicam—Hypotension—Methylprednisolone—ulcerative colitis	3.86e-05	0.000478	CcSEcCtD
Meloxicam—Pain—Prednisolone—ulcerative colitis	3.85e-05	0.000477	CcSEcCtD
Meloxicam—CYP2C9—Phase 1 - Functionalization of compounds—PTGS1—ulcerative colitis	3.83e-05	0.00366	CbGpPWpGaD
Meloxicam—Decreased appetite—Hydrocortisone—ulcerative colitis	3.82e-05	0.000474	CcSEcCtD
Meloxicam—Gastrointestinal disorder—Hydrocortisone—ulcerative colitis	3.8e-05	0.00047	CcSEcCtD
Meloxicam—Fatigue—Hydrocortisone—ulcerative colitis	3.79e-05	0.00047	CcSEcCtD
Meloxicam—PTGS1—Selenium Micronutrient Network—CRP—ulcerative colitis	3.78e-05	0.00362	CbGpPWpGaD
Meloxicam—Vision blurred—Prednisone—ulcerative colitis	3.78e-05	0.000468	CcSEcCtD
Meloxicam—Musculoskeletal discomfort—Triamcinolone—ulcerative colitis	3.77e-05	0.000468	CcSEcCtD
Meloxicam—Musculoskeletal discomfort—Methylprednisolone—ulcerative colitis	3.76e-05	0.000466	CcSEcCtD
Meloxicam—Pain—Hydrocortisone—ulcerative colitis	3.76e-05	0.000466	CcSEcCtD
Meloxicam—Anaphylactic shock—Betamethasone—ulcerative colitis	3.76e-05	0.000466	CcSEcCtD
Meloxicam—Anaphylactic shock—Dexamethasone—ulcerative colitis	3.76e-05	0.000466	CcSEcCtD
Meloxicam—Oedema—Dexamethasone—ulcerative colitis	3.76e-05	0.000466	CcSEcCtD
Meloxicam—Oedema—Betamethasone—ulcerative colitis	3.76e-05	0.000466	CcSEcCtD
Meloxicam—Insomnia—Triamcinolone—ulcerative colitis	3.74e-05	0.000464	CcSEcCtD
Meloxicam—PTGS2—Overview of nanoparticle effects—IL6—ulcerative colitis	3.74e-05	0.00358	CbGpPWpGaD
Meloxicam—Insomnia—Methylprednisolone—ulcerative colitis	3.74e-05	0.000463	CcSEcCtD
Meloxicam—Infection—Betamethasone—ulcerative colitis	3.73e-05	0.000463	CcSEcCtD
Meloxicam—Infection—Dexamethasone—ulcerative colitis	3.73e-05	0.000463	CcSEcCtD
Meloxicam—Ill-defined disorder—Prednisone—ulcerative colitis	3.72e-05	0.000461	CcSEcCtD
Meloxicam—Paraesthesia—Triamcinolone—ulcerative colitis	3.72e-05	0.000461	CcSEcCtD
Meloxicam—Feeling abnormal—Prednisolone—ulcerative colitis	3.71e-05	0.00046	CcSEcCtD
Meloxicam—Paraesthesia—Methylprednisolone—ulcerative colitis	3.71e-05	0.00046	CcSEcCtD
Meloxicam—Anaemia—Prednisone—ulcerative colitis	3.7e-05	0.000459	CcSEcCtD
Meloxicam—Shock—Betamethasone—ulcerative colitis	3.7e-05	0.000458	CcSEcCtD
Meloxicam—Shock—Dexamethasone—ulcerative colitis	3.7e-05	0.000458	CcSEcCtD
Meloxicam—Dyspnoea—Triamcinolone—ulcerative colitis	3.69e-05	0.000457	CcSEcCtD
Meloxicam—Nervous system disorder—Dexamethasone—ulcerative colitis	3.68e-05	0.000457	CcSEcCtD
Meloxicam—Nervous system disorder—Betamethasone—ulcerative colitis	3.68e-05	0.000457	CcSEcCtD
Meloxicam—Thrombocytopenia—Betamethasone—ulcerative colitis	3.68e-05	0.000456	CcSEcCtD
Meloxicam—Thrombocytopenia—Dexamethasone—ulcerative colitis	3.68e-05	0.000456	CcSEcCtD
Meloxicam—Nausea—Mesalazine—ulcerative colitis	3.67e-05	0.000455	CcSEcCtD
Meloxicam—Tachycardia—Dexamethasone—ulcerative colitis	3.67e-05	0.000454	CcSEcCtD
Meloxicam—Tachycardia—Betamethasone—ulcerative colitis	3.67e-05	0.000454	CcSEcCtD
Meloxicam—Angioedema—Prednisone—ulcerative colitis	3.66e-05	0.000454	CcSEcCtD
Meloxicam—Dyspepsia—Triamcinolone—ulcerative colitis	3.64e-05	0.000452	CcSEcCtD
Meloxicam—Dyspepsia—Methylprednisolone—ulcerative colitis	3.64e-05	0.000451	CcSEcCtD
Meloxicam—Hyperhidrosis—Betamethasone—ulcerative colitis	3.63e-05	0.00045	CcSEcCtD
Meloxicam—Hyperhidrosis—Dexamethasone—ulcerative colitis	3.63e-05	0.00045	CcSEcCtD
Meloxicam—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—ulcerative colitis	3.63e-05	0.00347	CbGpPWpGaD
Meloxicam—Feeling abnormal—Hydrocortisone—ulcerative colitis	3.62e-05	0.000449	CcSEcCtD
Meloxicam—Malaise—Prednisone—ulcerative colitis	3.61e-05	0.000448	CcSEcCtD
Meloxicam—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—ulcerative colitis	3.61e-05	0.00345	CbGpPWpGaD
Meloxicam—Vertigo—Prednisone—ulcerative colitis	3.6e-05	0.000446	CcSEcCtD
Meloxicam—Gastrointestinal pain—Hydrocortisone—ulcerative colitis	3.59e-05	0.000446	CcSEcCtD
Meloxicam—Syncope—Prednisone—ulcerative colitis	3.59e-05	0.000446	CcSEcCtD
Meloxicam—Urticaria—Prednisolone—ulcerative colitis	3.58e-05	0.000443	CcSEcCtD
Meloxicam—Fatigue—Triamcinolone—ulcerative colitis	3.57e-05	0.000442	CcSEcCtD
Meloxicam—Fatigue—Methylprednisolone—ulcerative colitis	3.56e-05	0.000441	CcSEcCtD
Meloxicam—Pain—Triamcinolone—ulcerative colitis	3.54e-05	0.000439	CcSEcCtD
Meloxicam—Loss of consciousness—Prednisone—ulcerative colitis	3.52e-05	0.000437	CcSEcCtD
Meloxicam—Hypotension—Betamethasone—ulcerative colitis	3.51e-05	0.000435	CcSEcCtD
Meloxicam—Hypotension—Dexamethasone—ulcerative colitis	3.51e-05	0.000435	CcSEcCtD
Meloxicam—Urticaria—Hydrocortisone—ulcerative colitis	3.49e-05	0.000433	CcSEcCtD
Meloxicam—PTGS2—Aryl Hydrocarbon Receptor—RELA—ulcerative colitis	3.48e-05	0.00333	CbGpPWpGaD
Meloxicam—PTGS1—Selenium Micronutrient Network—ICAM1—ulcerative colitis	3.48e-05	0.00332	CbGpPWpGaD
Meloxicam—Body temperature increased—Hydrocortisone—ulcerative colitis	3.48e-05	0.000431	CcSEcCtD
Meloxicam—Abdominal pain—Hydrocortisone—ulcerative colitis	3.48e-05	0.000431	CcSEcCtD
Meloxicam—Convulsion—Prednisone—ulcerative colitis	3.47e-05	0.00043	CcSEcCtD
Meloxicam—Hypertension—Prednisone—ulcerative colitis	3.46e-05	0.000429	CcSEcCtD
Meloxicam—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—ulcerative colitis	3.44e-05	0.00329	CbGpPWpGaD
Meloxicam—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—ulcerative colitis	3.43e-05	0.00328	CbGpPWpGaD
Meloxicam—PGD—Disease—SLC11A1—ulcerative colitis	3.43e-05	0.00328	CbGpPWpGaD
Meloxicam—Musculoskeletal discomfort—Betamethasone—ulcerative colitis	3.42e-05	0.000424	CcSEcCtD
Meloxicam—Musculoskeletal discomfort—Dexamethasone—ulcerative colitis	3.42e-05	0.000424	CcSEcCtD
Meloxicam—Myalgia—Prednisone—ulcerative colitis	3.41e-05	0.000423	CcSEcCtD
Meloxicam—Arthralgia—Prednisone—ulcerative colitis	3.41e-05	0.000423	CcSEcCtD
Meloxicam—Feeling abnormal—Triamcinolone—ulcerative colitis	3.41e-05	0.000423	CcSEcCtD
Meloxicam—Feeling abnormal—Methylprednisolone—ulcerative colitis	3.4e-05	0.000422	CcSEcCtD
Meloxicam—Anxiety—Prednisone—ulcerative colitis	3.4e-05	0.000422	CcSEcCtD
Meloxicam—Insomnia—Dexamethasone—ulcerative colitis	3.4e-05	0.000421	CcSEcCtD
Meloxicam—Insomnia—Betamethasone—ulcerative colitis	3.4e-05	0.000421	CcSEcCtD
Meloxicam—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ulcerative colitis	3.39e-05	0.00042	CcSEcCtD
Meloxicam—Gastrointestinal pain—Methylprednisolone—ulcerative colitis	3.38e-05	0.000419	CcSEcCtD
Meloxicam—Paraesthesia—Dexamethasone—ulcerative colitis	3.37e-05	0.000418	CcSEcCtD
Meloxicam—Paraesthesia—Betamethasone—ulcerative colitis	3.37e-05	0.000418	CcSEcCtD
Meloxicam—Discomfort—Prednisone—ulcerative colitis	3.37e-05	0.000418	CcSEcCtD
Meloxicam—Hypersensitivity—Prednisolone—ulcerative colitis	3.32e-05	0.000411	CcSEcCtD
Meloxicam—Dyspepsia—Dexamethasone—ulcerative colitis	3.31e-05	0.00041	CcSEcCtD
Meloxicam—Dyspepsia—Betamethasone—ulcerative colitis	3.31e-05	0.00041	CcSEcCtD
Meloxicam—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—ulcerative colitis	3.3e-05	0.00316	CbGpPWpGaD
Meloxicam—Urticaria—Triamcinolone—ulcerative colitis	3.29e-05	0.000408	CcSEcCtD
Meloxicam—Urticaria—Methylprednisolone—ulcerative colitis	3.28e-05	0.000407	CcSEcCtD
Meloxicam—Body temperature increased—Triamcinolone—ulcerative colitis	3.27e-05	0.000406	CcSEcCtD
Meloxicam—Anaphylactic shock—Prednisone—ulcerative colitis	3.27e-05	0.000405	CcSEcCtD
Meloxicam—Oedema—Prednisone—ulcerative colitis	3.27e-05	0.000405	CcSEcCtD
Meloxicam—Abdominal pain—Methylprednisolone—ulcerative colitis	3.27e-05	0.000405	CcSEcCtD
Meloxicam—Decreased appetite—Betamethasone—ulcerative colitis	3.27e-05	0.000405	CcSEcCtD
Meloxicam—Decreased appetite—Dexamethasone—ulcerative colitis	3.27e-05	0.000405	CcSEcCtD
Meloxicam—Infection—Prednisone—ulcerative colitis	3.25e-05	0.000403	CcSEcCtD
Meloxicam—Gastrointestinal disorder—Dexamethasone—ulcerative colitis	3.24e-05	0.000402	CcSEcCtD
Meloxicam—Gastrointestinal disorder—Betamethasone—ulcerative colitis	3.24e-05	0.000402	CcSEcCtD
Meloxicam—Hypersensitivity—Hydrocortisone—ulcerative colitis	3.24e-05	0.000402	CcSEcCtD
Meloxicam—Fatigue—Betamethasone—ulcerative colitis	3.24e-05	0.000401	CcSEcCtD
Meloxicam—Fatigue—Dexamethasone—ulcerative colitis	3.24e-05	0.000401	CcSEcCtD
Meloxicam—Shock—Prednisone—ulcerative colitis	3.22e-05	0.000399	CcSEcCtD
Meloxicam—Pain—Betamethasone—ulcerative colitis	3.21e-05	0.000398	CcSEcCtD
Meloxicam—Pain—Dexamethasone—ulcerative colitis	3.21e-05	0.000398	CcSEcCtD
Meloxicam—Nervous system disorder—Prednisone—ulcerative colitis	3.21e-05	0.000398	CcSEcCtD
Meloxicam—Tachycardia—Prednisone—ulcerative colitis	3.19e-05	0.000396	CcSEcCtD
Meloxicam—Skin disorder—Prednisone—ulcerative colitis	3.18e-05	0.000394	CcSEcCtD
Meloxicam—PTGS2—Integrated Pancreatic Cancer Pathway—HNF4A—ulcerative colitis	3.17e-05	0.00303	CbGpPWpGaD
Meloxicam—Hyperhidrosis—Prednisone—ulcerative colitis	3.16e-05	0.000392	CcSEcCtD
Meloxicam—Asthenia—Hydrocortisone—ulcerative colitis	3.15e-05	0.000391	CcSEcCtD
Meloxicam—Pruritus—Hydrocortisone—ulcerative colitis	3.11e-05	0.000386	CcSEcCtD
Meloxicam—Feeling abnormal—Dexamethasone—ulcerative colitis	3.1e-05	0.000384	CcSEcCtD
Meloxicam—Feeling abnormal—Betamethasone—ulcerative colitis	3.1e-05	0.000384	CcSEcCtD
Meloxicam—PGD—Disease—MAML2—ulcerative colitis	3.08e-05	0.00295	CbGpPWpGaD
Meloxicam—Gastrointestinal pain—Betamethasone—ulcerative colitis	3.07e-05	0.000381	CcSEcCtD
Meloxicam—Gastrointestinal pain—Dexamethasone—ulcerative colitis	3.07e-05	0.000381	CcSEcCtD
Meloxicam—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CXCL8—ulcerative colitis	3.07e-05	0.00294	CbGpPWpGaD
Meloxicam—Hypersensitivity—Triamcinolone—ulcerative colitis	3.05e-05	0.000378	CcSEcCtD
Meloxicam—Hypersensitivity—Methylprednisolone—ulcerative colitis	3.04e-05	0.000377	CcSEcCtD
Meloxicam—Diarrhoea—Hydrocortisone—ulcerative colitis	3.01e-05	0.000373	CcSEcCtD
Meloxicam—PTGS2—Selenium Micronutrient Network—CRP—ulcerative colitis	3e-05	0.00287	CbGpPWpGaD
Meloxicam—ABCC4—Hemostasis—GNA12—ulcerative colitis	3e-05	0.00287	CbGpPWpGaD
Meloxicam—Urticaria—Dexamethasone—ulcerative colitis	2.98e-05	0.00037	CcSEcCtD
Meloxicam—Urticaria—Betamethasone—ulcerative colitis	2.98e-05	0.00037	CcSEcCtD
Meloxicam—Musculoskeletal discomfort—Prednisone—ulcerative colitis	2.98e-05	0.000369	CcSEcCtD
Meloxicam—Dizziness—Prednisolone—ulcerative colitis	2.98e-05	0.000369	CcSEcCtD
Meloxicam—Asthenia—Triamcinolone—ulcerative colitis	2.97e-05	0.000368	CcSEcCtD
Meloxicam—Abdominal pain—Dexamethasone—ulcerative colitis	2.97e-05	0.000368	CcSEcCtD
Meloxicam—Abdominal pain—Betamethasone—ulcerative colitis	2.97e-05	0.000368	CcSEcCtD
Meloxicam—Body temperature increased—Dexamethasone—ulcerative colitis	2.97e-05	0.000368	CcSEcCtD
Meloxicam—Body temperature increased—Betamethasone—ulcerative colitis	2.97e-05	0.000368	CcSEcCtD
Meloxicam—Asthenia—Methylprednisolone—ulcerative colitis	2.96e-05	0.000367	CcSEcCtD
Meloxicam—Insomnia—Prednisone—ulcerative colitis	2.96e-05	0.000367	CcSEcCtD
Meloxicam—ABCC4—Hemostasis—ITGAL—ulcerative colitis	2.95e-05	0.00282	CbGpPWpGaD
Meloxicam—PTGS2—Aryl Hydrocarbon Receptor—NFKB1—ulcerative colitis	2.94e-05	0.00281	CbGpPWpGaD
Meloxicam—Paraesthesia—Prednisone—ulcerative colitis	2.94e-05	0.000364	CcSEcCtD
Meloxicam—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—ulcerative colitis	2.94e-05	0.00281	CbGpPWpGaD
Meloxicam—Pruritus—Triamcinolone—ulcerative colitis	2.93e-05	0.000363	CcSEcCtD
Meloxicam—Pruritus—Methylprednisolone—ulcerative colitis	2.92e-05	0.000362	CcSEcCtD
Meloxicam—Dizziness—Hydrocortisone—ulcerative colitis	2.91e-05	0.00036	CcSEcCtD
Meloxicam—PTGS1—Selenium Micronutrient Network—ALB—ulcerative colitis	2.9e-05	0.00277	CbGpPWpGaD
Meloxicam—Dyspepsia—Prednisone—ulcerative colitis	2.88e-05	0.000357	CcSEcCtD
Meloxicam—Decreased appetite—Prednisone—ulcerative colitis	2.84e-05	0.000352	CcSEcCtD
Meloxicam—Rash—Prednisolone—ulcerative colitis	2.84e-05	0.000352	CcSEcCtD
Meloxicam—Dermatitis—Prednisolone—ulcerative colitis	2.84e-05	0.000351	CcSEcCtD
Meloxicam—Diarrhoea—Methylprednisolone—ulcerative colitis	2.83e-05	0.00035	CcSEcCtD
Meloxicam—Fatigue—Prednisone—ulcerative colitis	2.82e-05	0.00035	CcSEcCtD
Meloxicam—Headache—Prednisolone—ulcerative colitis	2.82e-05	0.00035	CcSEcCtD
Meloxicam—ABCC4—Platelet degranulation—TGFB1—ulcerative colitis	2.81e-05	0.00269	CbGpPWpGaD
Meloxicam—Constipation—Prednisone—ulcerative colitis	2.8e-05	0.000347	CcSEcCtD
Meloxicam—Vomiting—Hydrocortisone—ulcerative colitis	2.8e-05	0.000346	CcSEcCtD
Meloxicam—Rash—Hydrocortisone—ulcerative colitis	2.77e-05	0.000344	CcSEcCtD
Meloxicam—Dermatitis—Hydrocortisone—ulcerative colitis	2.77e-05	0.000343	CcSEcCtD
Meloxicam—PTGS2—Selenium Micronutrient Network—ICAM1—ulcerative colitis	2.76e-05	0.00264	CbGpPWpGaD
Meloxicam—Headache—Hydrocortisone—ulcerative colitis	2.75e-05	0.000341	CcSEcCtD
Meloxicam—Dizziness—Triamcinolone—ulcerative colitis	2.74e-05	0.000339	CcSEcCtD
Meloxicam—Dizziness—Methylprednisolone—ulcerative colitis	2.73e-05	0.000339	CcSEcCtD
Meloxicam—Feeling abnormal—Prednisone—ulcerative colitis	2.7e-05	0.000334	CcSEcCtD
Meloxicam—Asthenia—Betamethasone—ulcerative colitis	2.69e-05	0.000334	CcSEcCtD
Meloxicam—Asthenia—Dexamethasone—ulcerative colitis	2.69e-05	0.000334	CcSEcCtD
Meloxicam—ABCC4—Response to elevated platelet cytosolic Ca2+—TGFB1—ulcerative colitis	2.68e-05	0.00256	CbGpPWpGaD
Meloxicam—Gastrointestinal pain—Prednisone—ulcerative colitis	2.67e-05	0.000332	CcSEcCtD
Meloxicam—Nausea—Prednisolone—ulcerative colitis	2.67e-05	0.000331	CcSEcCtD
Meloxicam—Pruritus—Dexamethasone—ulcerative colitis	2.66e-05	0.000329	CcSEcCtD
Meloxicam—Pruritus—Betamethasone—ulcerative colitis	2.66e-05	0.000329	CcSEcCtD
Meloxicam—PTGS1—Selenium Micronutrient Network—IFNG—ulcerative colitis	2.65e-05	0.00253	CbGpPWpGaD
Meloxicam—Vomiting—Triamcinolone—ulcerative colitis	2.63e-05	0.000326	CcSEcCtD
Meloxicam—Vomiting—Methylprednisolone—ulcerative colitis	2.63e-05	0.000326	CcSEcCtD
Meloxicam—PTGS1—Selenium Micronutrient Network—RELA—ulcerative colitis	2.61e-05	0.0025	CbGpPWpGaD
Meloxicam—Nausea—Hydrocortisone—ulcerative colitis	2.61e-05	0.000324	CcSEcCtD
Meloxicam—Rash—Triamcinolone—ulcerative colitis	2.61e-05	0.000324	CcSEcCtD
Meloxicam—Dermatitis—Triamcinolone—ulcerative colitis	2.61e-05	0.000323	CcSEcCtD
Meloxicam—Rash—Methylprednisolone—ulcerative colitis	2.6e-05	0.000323	CcSEcCtD
Meloxicam—Dermatitis—Methylprednisolone—ulcerative colitis	2.6e-05	0.000323	CcSEcCtD
Meloxicam—Urticaria—Prednisone—ulcerative colitis	2.6e-05	0.000322	CcSEcCtD
Meloxicam—Headache—Triamcinolone—ulcerative colitis	2.59e-05	0.000321	CcSEcCtD
Meloxicam—Headache—Methylprednisolone—ulcerative colitis	2.59e-05	0.000321	CcSEcCtD
Meloxicam—Abdominal pain—Prednisone—ulcerative colitis	2.59e-05	0.000321	CcSEcCtD
Meloxicam—Body temperature increased—Prednisone—ulcerative colitis	2.59e-05	0.000321	CcSEcCtD
Meloxicam—CYP2C8—Arachidonic acid metabolism—PTGS2—ulcerative colitis	2.58e-05	0.00246	CbGpPWpGaD
Meloxicam—Diarrhoea—Betamethasone—ulcerative colitis	2.57e-05	0.000319	CcSEcCtD
Meloxicam—Diarrhoea—Dexamethasone—ulcerative colitis	2.57e-05	0.000319	CcSEcCtD
Meloxicam—PGD—Disease—CALM3—ulcerative colitis	2.54e-05	0.00243	CbGpPWpGaD
Meloxicam—PTGS1—Selenium Micronutrient Network—PTGS2—ulcerative colitis	2.54e-05	0.00243	CbGpPWpGaD
Meloxicam—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—ulcerative colitis	2.53e-05	0.00242	CbGpPWpGaD
Meloxicam—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—ulcerative colitis	2.51e-05	0.0024	CbGpPWpGaD
Meloxicam—CYP2C8—Biological oxidations—PTGS1—ulcerative colitis	2.5e-05	0.00239	CbGpPWpGaD
Meloxicam—Dizziness—Betamethasone—ulcerative colitis	2.48e-05	0.000308	CcSEcCtD
Meloxicam—Dizziness—Dexamethasone—ulcerative colitis	2.48e-05	0.000308	CcSEcCtD
Meloxicam—Nausea—Triamcinolone—ulcerative colitis	2.46e-05	0.000305	CcSEcCtD
Meloxicam—Nausea—Methylprednisolone—ulcerative colitis	2.45e-05	0.000304	CcSEcCtD
Meloxicam—ABCC4—Transmembrane transport of small molecules—SLC11A1—ulcerative colitis	2.44e-05	0.00233	CbGpPWpGaD
Meloxicam—Hypersensitivity—Prednisone—ulcerative colitis	2.41e-05	0.000299	CcSEcCtD
Meloxicam—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—ulcerative colitis	2.39e-05	0.00229	CbGpPWpGaD
Meloxicam—Vomiting—Dexamethasone—ulcerative colitis	2.39e-05	0.000296	CcSEcCtD
Meloxicam—Vomiting—Betamethasone—ulcerative colitis	2.39e-05	0.000296	CcSEcCtD
Meloxicam—Rash—Dexamethasone—ulcerative colitis	2.37e-05	0.000294	CcSEcCtD
Meloxicam—Rash—Betamethasone—ulcerative colitis	2.37e-05	0.000294	CcSEcCtD
Meloxicam—Dermatitis—Betamethasone—ulcerative colitis	2.37e-05	0.000293	CcSEcCtD
Meloxicam—Dermatitis—Dexamethasone—ulcerative colitis	2.37e-05	0.000293	CcSEcCtD
Meloxicam—PGD—Metabolism—PTGS1—ulcerative colitis	2.36e-05	0.00226	CbGpPWpGaD
Meloxicam—PTGS1—Selenium Micronutrient Network—IL1B—ulcerative colitis	2.36e-05	0.00226	CbGpPWpGaD
Meloxicam—Headache—Dexamethasone—ulcerative colitis	2.35e-05	0.000292	CcSEcCtD
Meloxicam—Headache—Betamethasone—ulcerative colitis	2.35e-05	0.000292	CcSEcCtD
Meloxicam—Asthenia—Prednisone—ulcerative colitis	2.35e-05	0.000291	CcSEcCtD
Meloxicam—Pruritus—Prednisone—ulcerative colitis	2.31e-05	0.000287	CcSEcCtD
Meloxicam—PTGS2—Selenium Micronutrient Network—ALB—ulcerative colitis	2.3e-05	0.0022	CbGpPWpGaD
Meloxicam—PTGS2—Aryl Hydrocarbon Receptor—TNF—ulcerative colitis	2.29e-05	0.00218	CbGpPWpGaD
Meloxicam—PTGS2—Spinal Cord Injury—TLR4—ulcerative colitis	2.28e-05	0.00218	CbGpPWpGaD
Meloxicam—Diarrhoea—Prednisone—ulcerative colitis	2.24e-05	0.000277	CcSEcCtD
Meloxicam—Nausea—Dexamethasone—ulcerative colitis	2.23e-05	0.000277	CcSEcCtD
Meloxicam—Nausea—Betamethasone—ulcerative colitis	2.23e-05	0.000277	CcSEcCtD
Meloxicam—PTGS1—Selenium Micronutrient Network—NFKB1—ulcerative colitis	2.2e-05	0.00211	CbGpPWpGaD
Meloxicam—PTGS2—Spinal Cord Injury—ICAM1—ulcerative colitis	2.18e-05	0.00209	CbGpPWpGaD
Meloxicam—Dizziness—Prednisone—ulcerative colitis	2.16e-05	0.000268	CcSEcCtD
Meloxicam—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—ulcerative colitis	2.14e-05	0.00204	CbGpPWpGaD
Meloxicam—PGD—Metabolism—CALM3—ulcerative colitis	2.13e-05	0.00203	CbGpPWpGaD
Meloxicam—PTGS2—C-MYB transcription factor network—CD4—ulcerative colitis	2.11e-05	0.00201	CbGpPWpGaD
Meloxicam—PTGS2—Selenium Micronutrient Network—IFNG—ulcerative colitis	2.1e-05	0.00201	CbGpPWpGaD
Meloxicam—CYP2C9—Arachidonic acid metabolism—PTGS2—ulcerative colitis	2.1e-05	0.002	CbGpPWpGaD
Meloxicam—ABCC4—Hemostasis—CALM3—ulcerative colitis	2.09e-05	0.002	CbGpPWpGaD
Meloxicam—Vomiting—Prednisone—ulcerative colitis	2.08e-05	0.000258	CcSEcCtD
Meloxicam—PTGS2—Selenium Micronutrient Network—RELA—ulcerative colitis	2.07e-05	0.00198	CbGpPWpGaD
Meloxicam—Rash—Prednisone—ulcerative colitis	2.06e-05	0.000256	CcSEcCtD
Meloxicam—Dermatitis—Prednisone—ulcerative colitis	2.06e-05	0.000255	CcSEcCtD
Meloxicam—Headache—Prednisone—ulcerative colitis	2.05e-05	0.000254	CcSEcCtD
Meloxicam—CYP2C9—Biological oxidations—PTGS1—ulcerative colitis	2.04e-05	0.00195	CbGpPWpGaD
Meloxicam—PTGS2—Integrated Pancreatic Cancer Pathway—ABCB1—ulcerative colitis	1.98e-05	0.00189	CbGpPWpGaD
Meloxicam—ABCC4—Platelet activation, signaling and aggregation—ALB—ulcerative colitis	1.97e-05	0.00188	CbGpPWpGaD
Meloxicam—Nausea—Prednisone—ulcerative colitis	1.94e-05	0.000241	CcSEcCtD
Meloxicam—PTGS2—Selenium Micronutrient Network—IL1B—ulcerative colitis	1.87e-05	0.00179	CbGpPWpGaD
Meloxicam—PGD—Disease—ADCY5—ulcerative colitis	1.84e-05	0.00176	CbGpPWpGaD
Meloxicam—ABCC4—Platelet activation, signaling and aggregation—JAK2—ulcerative colitis	1.83e-05	0.00175	CbGpPWpGaD
Meloxicam—PTGS2—Selenium Micronutrient Network—NFKB1—ulcerative colitis	1.75e-05	0.00167	CbGpPWpGaD
Meloxicam—ABCC4—NRF2 pathway—TGFB1—ulcerative colitis	1.74e-05	0.00166	CbGpPWpGaD
Meloxicam—PTGS1—Selenium Micronutrient Network—TNF—ulcerative colitis	1.71e-05	0.00164	CbGpPWpGaD
Meloxicam—PTGS2—Spinal Cord Injury—IFNG—ulcerative colitis	1.66e-05	0.00159	CbGpPWpGaD
Meloxicam—PGD—Metabolism—ABCB1—ulcerative colitis	1.65e-05	0.00158	CbGpPWpGaD
Meloxicam—ABCC4—Platelet activation, signaling and aggregation—IL2—ulcerative colitis	1.6e-05	0.00153	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—CHP1—ulcerative colitis	1.59e-05	0.00152	CbGpPWpGaD
Meloxicam—PTGS2—Spinal Cord Injury—CXCL8—ulcerative colitis	1.55e-05	0.00148	CbGpPWpGaD
Meloxicam—PGD—Metabolism—ADCY5—ulcerative colitis	1.54e-05	0.00147	CbGpPWpGaD
Meloxicam—PTGS2—Disease—CHP1—ulcerative colitis	1.5e-05	0.00144	CbGpPWpGaD
Meloxicam—PTGS2—Spinal Cord Injury—IL1B—ulcerative colitis	1.48e-05	0.00142	CbGpPWpGaD
Meloxicam—PTGS2—Spinal Cord Injury—IL2—ulcerative colitis	1.48e-05	0.00141	CbGpPWpGaD
Meloxicam—ABCC4—Transmembrane transport of small molecules—ABCB1—ulcerative colitis	1.41e-05	0.00134	CbGpPWpGaD
Meloxicam—PTGS2—Spinal Cord Injury—MMP9—ulcerative colitis	1.4e-05	0.00134	CbGpPWpGaD
Meloxicam—PTGS1—Selenium Micronutrient Network—IL6—ulcerative colitis	1.38e-05	0.00132	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—DLD—ulcerative colitis	1.37e-05	0.00131	CbGpPWpGaD
Meloxicam—PTGS2—Selenium Micronutrient Network—TNF—ulcerative colitis	1.36e-05	0.0013	CbGpPWpGaD
Meloxicam—CYP3A4—Biological oxidations—PTGS1—ulcerative colitis	1.34e-05	0.00128	CbGpPWpGaD
Meloxicam—ABCC4—Hemostasis—MMP1—ulcerative colitis	1.34e-05	0.00128	CbGpPWpGaD
Meloxicam—ABCC4—Transmembrane transport of small molecules—ADCY5—ulcerative colitis	1.31e-05	0.00125	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—CHP1—ulcerative colitis	1.26e-05	0.0012	CbGpPWpGaD
Meloxicam—ABCC4—Platelet activation, signaling and aggregation—TGFB1—ulcerative colitis	1.25e-05	0.00119	CbGpPWpGaD
Meloxicam—PTGS2—Disease—SEL1L—ulcerative colitis	1.2e-05	0.00114	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	1.18e-05	0.00113	CbGpPWpGaD
Meloxicam—PTGS2—Spinal Cord Injury—TGFB1—ulcerative colitis	1.15e-05	0.0011	CbGpPWpGaD
Meloxicam—PGD—Metabolism—PPARG—ulcerative colitis	1.15e-05	0.0011	CbGpPWpGaD
Meloxicam—PGD—Disease—JAK2—ulcerative colitis	1.15e-05	0.0011	CbGpPWpGaD
Meloxicam—PTGS2—Selenium Micronutrient Network—IL6—ulcerative colitis	1.1e-05	0.00105	CbGpPWpGaD
Meloxicam—PGD—Disease—CD4—ulcerative colitis	1.09e-05	0.00104	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—DLD—ulcerative colitis	1.09e-05	0.00104	CbGpPWpGaD
Meloxicam—PGD—Disease—PTGS2—ulcerative colitis	1.08e-05	0.00103	CbGpPWpGaD
Meloxicam—PTGS2—Spinal Cord Injury—TNF—ulcerative colitis	1.08e-05	0.00103	CbGpPWpGaD
Meloxicam—PTGS2—Disease—LTF—ulcerative colitis	1.07e-05	0.00102	CbGpPWpGaD
Meloxicam—PGD—Metabolism—ALB—ulcerative colitis	1.03e-05	0.000989	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—CHP1—ulcerative colitis	1.03e-05	0.00098	CbGpPWpGaD
Meloxicam—ABCC4—Hemostasis—ALB—ulcerative colitis	1.02e-05	0.000971	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	9.61e-06	0.000918	CbGpPWpGaD
Meloxicam—PTGS2—Spinal Cord Injury—TP53—ulcerative colitis	9.48e-06	0.000906	CbGpPWpGaD
Meloxicam—ABCC4—Hemostasis—JAK2—ulcerative colitis	9.45e-06	0.000903	CbGpPWpGaD
Meloxicam—PTGS2—Integrated Pancreatic Cancer Pathway—NFKB1—ulcerative colitis	9.41e-06	0.000899	CbGpPWpGaD
Meloxicam—PGD—Metabolism—PTGS2—ulcerative colitis	9.05e-06	0.000865	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—DLD—ulcerative colitis	8.85e-06	0.000846	CbGpPWpGaD
Meloxicam—ABCC4—Transmembrane transport of small molecules—ALB—ulcerative colitis	8.79e-06	0.000841	CbGpPWpGaD
Meloxicam—PTGS2—Spinal Cord Injury—IL6—ulcerative colitis	8.68e-06	0.00083	CbGpPWpGaD
Meloxicam—PGD—Disease—STAT3—ulcerative colitis	8.43e-06	0.000806	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—CHP1—ulcerative colitis	8.35e-06	0.000798	CbGpPWpGaD
Meloxicam—ABCC4—Hemostasis—IL2—ulcerative colitis	8.24e-06	0.000787	CbGpPWpGaD
Meloxicam—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—ulcerative colitis	7.84e-06	0.000749	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	7.82e-06	0.000747	CbGpPWpGaD
Meloxicam—PGD—Disease—TGFB1—ulcerative colitis	7.81e-06	0.000747	CbGpPWpGaD
Meloxicam—PTGS2—Disease—SLC11A1—ulcerative colitis	7.64e-06	0.00073	CbGpPWpGaD
Meloxicam—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—ulcerative colitis	7.32e-06	0.000699	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	7.25e-06	0.000693	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—DLD—ulcerative colitis	7.2e-06	0.000689	CbGpPWpGaD
Meloxicam—PTGS2—Disease—MAML2—ulcerative colitis	6.87e-06	0.000656	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	6.52e-06	0.000623	CbGpPWpGaD
Meloxicam—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—ulcerative colitis	6.45e-06	0.000617	CbGpPWpGaD
Meloxicam—ABCC4—Hemostasis—TGFB1—ulcerative colitis	6.43e-06	0.000614	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—CALM3—ulcerative colitis	5.97e-06	0.00057	CbGpPWpGaD
Meloxicam—PGD—Disease—IL6—ulcerative colitis	5.89e-06	0.000563	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	5.75e-06	0.00055	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	5.7e-06	0.000545	CbGpPWpGaD
Meloxicam—PTGS2—Disease—CALM3—ulcerative colitis	5.65e-06	0.00054	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—CHP1—ulcerative colitis	5.5e-06	0.000526	CbGpPWpGaD
Meloxicam—ABCC4—Hemostasis—TP53—ulcerative colitis	5.29e-06	0.000506	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—PTGS1—ulcerative colitis	5.26e-06	0.000503	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	5.17e-06	0.000494	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—DLD—ulcerative colitis	4.75e-06	0.000454	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—CALM3—ulcerative colitis	4.74e-06	0.000453	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	4.68e-06	0.000447	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—ABCB1—ulcerative colitis	4.64e-06	0.000443	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—ADCY5—ulcerative colitis	4.33e-06	0.000414	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—PTGS1—ulcerative colitis	4.28e-06	0.000409	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	4.21e-06	0.000402	CbGpPWpGaD
Meloxicam—PTGS2—Disease—ADCY5—ulcerative colitis	4.1e-06	0.000392	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—CALM3—ulcerative colitis	3.85e-06	0.000368	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	3.81e-06	0.000364	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—ABCB1—ulcerative colitis	3.68e-06	0.000352	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	3.68e-06	0.000352	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—PTGS1—ulcerative colitis	3.48e-06	0.000333	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—ADCY5—ulcerative colitis	3.44e-06	0.000328	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	3.43e-06	0.000327	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—PPARG—ulcerative colitis	3.23e-06	0.000308	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—CALM3—ulcerative colitis	3.14e-06	0.0003	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	3e-06	0.000286	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—ABCB1—ulcerative colitis	3e-06	0.000286	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—ALB—ulcerative colitis	2.9e-06	0.000277	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—ADCY5—ulcerative colitis	2.8e-06	0.000267	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—PPARG—ulcerative colitis	2.56e-06	0.000245	CbGpPWpGaD
Meloxicam—PTGS2—Disease—JAK2—ulcerative colitis	2.56e-06	0.000244	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—PTGS2—ulcerative colitis	2.54e-06	0.000243	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—ABCB1—ulcerative colitis	2.44e-06	0.000233	CbGpPWpGaD
Meloxicam—PTGS2—Disease—CD4—ulcerative colitis	2.42e-06	0.000232	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—ALB—ulcerative colitis	2.3e-06	0.00022	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—PTGS1—ulcerative colitis	2.3e-06	0.00022	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—ADCY5—ulcerative colitis	2.28e-06	0.000217	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—PPARG—ulcerative colitis	2.08e-06	0.000199	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—CALM3—ulcerative colitis	2.07e-06	0.000198	CbGpPWpGaD
Meloxicam—PTGS2—Disease—STAT3—ulcerative colitis	1.88e-06	0.000179	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—ALB—ulcerative colitis	1.87e-06	0.000179	CbGpPWpGaD
Meloxicam—PTGS2—Disease—TGFB1—ulcerative colitis	1.74e-06	0.000166	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—PPARG—ulcerative colitis	1.7e-06	0.000162	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—PTGS2—ulcerative colitis	1.64e-06	0.000157	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—ABCB1—ulcerative colitis	1.61e-06	0.000154	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—ALB—ulcerative colitis	1.53e-06	0.000146	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—ADCY5—ulcerative colitis	1.5e-06	0.000143	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—PTGS2—ulcerative colitis	1.33e-06	0.000128	CbGpPWpGaD
Meloxicam—PTGS2—Disease—IL6—ulcerative colitis	1.31e-06	0.000125	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—PPARG—ulcerative colitis	1.12e-06	0.000107	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—ALB—ulcerative colitis	1.01e-06	9.62e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—PTGS2—ulcerative colitis	8.8e-07	8.41e-05	CbGpPWpGaD
